ArticleDermatology and therapy2024

Comparison of Drug-Free Remission after the End of Phase III Trials of Three Different Anti-IL-23 Inhibitors in Psoriasis.

Chang-Yu Hsieh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.